Getein Biotech, Inc (SHA:603387)
China flag China · Delayed Price · Currency is CNY
8.24
-0.31 (-3.63%)
Nov 13, 2026, 3:00 PM CST

Getein Biotech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,1141,0521,1651,3691,8221,402
Revenue Growth
6.86%-9.71%-14.93%-24.85%29.98%24.78%
Gross Profit
756.99712.11776.73889.451,150916.29
Operating Income
287.33208.88220.73212.24497.01409.59
Net Income
292.52220.66223.64279.77498.91398.99
Earnings Per Share
0.580.440.440.550.980.78
EPS Growth
41.37%0%-20.00%-43.88%25.64%30.00%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
China
868.15
Foreign
183.56
Total
1,052

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,6641,2271,000936.241,1571,582
Total Debt
277.28481.96581.57666.68591.02496.44
Net Cash (Debt)
1,387744.54418.9269.56566.371,085
Net Cash Growth
172.51%77.74%55.40%-52.41%-47.81%7.27%
Net Cash Per Share
2.751.480.820.531.112.12

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
442.65392.59423333.22482.96432.36
Capital Expenditures
-120.87-150.58-156.4-258.13-217.44-179.6
Free Cash Flow
321.78242.01266.675.09265.51252.77
Free Cash Flow Growth
73.36%-9.22%255.02%-71.72%5.04%251.38%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.94%67.71%66.68%64.96%63.14%65.37%
Operating Margin
25.79%19.86%18.95%15.50%27.28%29.22%
Pretax Margin
28.89%21.65%21.76%22.27%30.74%32.22%
Profit Margin
26.25%20.98%19.20%20.43%27.38%28.46%
FCF Margin
28.88%23.01%22.89%5.49%14.57%18.03%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3000.2400.1800.2000.3400.243
Dividend Per Share Growth
66.67%33.33%-10.00%-41.18%39.98%32.30%
Dividend Yield
3.64%2.87%2.18%1.82%2.72%1.70%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.2019.2418.7119.9412.7118.18
Forward PE
-17.4317.4317.4317.4317.43
P/FCF Ratio
12.9717.5415.6974.2923.8828.70
PS Ratio
3.754.043.594.083.485.18